Andrew Carragher


Andrew has considerable experience in building and operating healthcare companies, overseeing mergers and acquisitions, and raising capital.

Andrew is a Founder and Managing Director at DW Healthcare Partners . Prior to co-founding DWHP, Andrew was Vice President of Business Development at Ventro Corporation, a builder and aggregator of electronic marketplaces. Andrew joined Ventro prior to its IPO and was involved in the strategic planning and capital raising process, in which Ventro raised over $40 million in private capital and over $360 million in the public markets, both in the U.S. and Europe. He was also responsible for over $1.2 billion in mergers and acquisitions, including Ventro's purchase of Promedix Corporation and SpecialtyMD.

During his tenure at Ventro, Andrew helped create and raise capital for Broadlane, a joint venture between Tenet Healthcare and Ventro.

Prior to Ventro, Andrew was Director of Corporate Development/ Mergers and Acquisitions at Total Renal Care (now Davita), an operator of 500 dialysis clinics. Andrew completed over 25 transactions with an aggregate value of $2.3 billion. The company raised over $200 million in public equity, $250 million in public convertible debt, and over $1 billion in syndicated debt.

Before Total Renal Care, Andrew was a Divisional Manager at Weston Foods in New York City, a 200-employee manufacturing and distribution business in the bakery and confectionary business.

Andrew also worked for Bain & Company, a leading international strategy and consulting firm. While there, he advised clients in a number of industries, including telecommunications, airlines and real estate.

Andrew was raised in Toronto, Canada. He received his Bachelors degree in Business Administration from the University of Western Ontario and his MBA from Harvard Business School.

Andrew was recognized in 2006 as one of Utah's Top 40 Under 40 and is a member of the Young President's Organization (YPO) Utah Chapter.

© Pentec Health